| T2D | type 2 diabetes |
| CV | cardiovascular |
| GLP-1ra | glucagon-like peptide 1 receptor agonists |
| SGLT-2in | sodium-glucose cotransporter-2 inhibitors |
| CVD | cardiovascular disease |
| ADA | American Diabetes Association |
| EASD | European Association for the Study of Diabetes |
| HbA1c | hemoglobin A1c |
| LDL | low-density lipoprotein |
| HDL | high-density lipoprotein |
| CAD | coronary artery disease |
| ASCVD | atherosclerotic cardiovascular disease |
| CVOT’s | cardiovascular outcome trials |
| CHF | chronic heart failure |
| CKD | chronic kidney disease |
| AI | Artificial Intelligence |
| DKA | diabetic ketoacidosis |
| PS | propensity score |